Market Closed -
Nasdaq
04:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
22.15
USD
|
-4.24%
|
|
-0.54%
|
+48.36%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,340
|
17,615
|
7,795
|
7,698
|
1,595
|
2,384
|
-
|
-
|
Enterprise Value (EV)
1 |
8,312
|
17,810
|
8,148
|
8,148
|
1,923
|
2,293
|
2,443
|
2,384
|
P/E ratio
|
-1,204
x
|
865
x
|
-134
x
|
-83.4
x
|
-7.66
x
|
-13.8
x
|
-13
x
|
-13.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
23.7
x
|
35.6
x
|
14.6
x
|
14.3
x
|
3.13
x
|
4.31
x
|
4.03
x
|
3.62
x
|
EV / Revenue
|
23.7
x
|
36
x
|
15.2
x
|
15.1
x
|
3.78
x
|
4.15
x
|
4.13
x
|
3.62
x
|
EV / EBITDA
|
1,102
x
|
450
x
|
-239
x
|
-103
x
|
-8.67
x
|
-12
x
|
-12.4
x
|
-12.9
x
|
EV / FCF
|
515
x
|
212
x
|
139
x
|
864
x
|
-19.2
x
|
-21.6
x
|
-24.5
x
|
-22.7
x
|
FCF Yield
|
0.19%
|
0.47%
|
0.72%
|
0.12%
|
-5.22%
|
-4.63%
|
-4.08%
|
-4.41%
|
Price to Book
|
38.5
x
|
37.2
x
|
19
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
98,969
|
101,797
|
103,819
|
104,950
|
106,861
|
107,611
|
-
|
-
|
Reference price
2 |
84.27
|
173.0
|
75.08
|
73.35
|
14.93
|
22.15
|
22.15
|
22.15
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
351.3
|
494.4
|
535
|
537.8
|
509.3
|
552.5
|
592.1
|
657.8
|
EBITDA
1 |
7.546
|
39.55
|
-34.08
|
-78.9
|
-221.9
|
-191.5
|
-196.9
|
-185.2
|
EBIT
1 |
-0.914
|
30.4
|
-44.33
|
-89.52
|
-232.9
|
-196.1
|
-207.8
|
-195.1
|
Operating Margin
|
-0.26%
|
6.15%
|
-8.29%
|
-16.64%
|
-45.72%
|
-35.5%
|
-35.09%
|
-29.66%
|
Earnings before Tax (EBT)
1 |
-8.824
|
18.1
|
-52.08
|
-81.85
|
-191.7
|
-159.2
|
-180.9
|
-169
|
Net income
1 |
-7.23
|
19.81
|
-58.35
|
-92.53
|
-207
|
-175.3
|
-187.6
|
-179.1
|
Net margin
|
-2.06%
|
4.01%
|
-10.91%
|
-17.2%
|
-40.65%
|
-31.72%
|
-31.68%
|
-27.23%
|
EPS
2 |
-0.0700
|
0.2000
|
-0.5600
|
-0.8800
|
-1.950
|
-1.604
|
-1.710
|
-1.636
|
Free Cash Flow
1 |
16.14
|
84.18
|
58.59
|
9.43
|
-100.4
|
-106.1
|
-99.77
|
-105
|
FCF margin
|
4.59%
|
17.03%
|
10.95%
|
1.75%
|
-19.72%
|
-19.2%
|
-16.85%
|
-15.96%
|
FCF Conversion (EBITDA)
|
213.82%
|
212.84%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
424.98%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
133.2
|
137.5
|
140.9
|
131
|
128.4
|
122.2
|
126.1
|
127.3
|
133.8
|
138.5
|
135.8
|
138
|
140.3
|
148
|
147.9
|
EBITDA
1 |
-20.73
|
1.804
|
-18.47
|
-21.95
|
-40.28
|
-57.53
|
-59.94
|
-55.44
|
-48.99
|
-38.7
|
-51.6
|
-52
|
-50.42
|
-42.87
|
-53.94
|
EBIT
1 |
-23.4
|
-0.806
|
-21.13
|
-24.61
|
-42.98
|
-60.25
|
-62.66
|
-58.24
|
-51.72
|
-41.52
|
-50.05
|
-51.38
|
-53.08
|
-45.88
|
-57.01
|
Operating Margin
|
-17.56%
|
-0.59%
|
-15%
|
-18.79%
|
-33.46%
|
-49.31%
|
-49.71%
|
-45.75%
|
-38.66%
|
-29.98%
|
-36.85%
|
-37.23%
|
-37.83%
|
-30.99%
|
-38.53%
|
Earnings before Tax (EBT)
1 |
-25.57
|
-2.515
|
-23.36
|
-23.42
|
-32.56
|
-51.08
|
-53.9
|
-48.22
|
-38.53
|
-31.64
|
-40.86
|
-42.33
|
-44.31
|
-39.51
|
-50.63
|
Net income
1 |
-26.46
|
-4.647
|
-24.01
|
-26.58
|
-37.3
|
-53.06
|
-57.42
|
-49.48
|
-47.08
|
-38.76
|
-44.19
|
-45.35
|
-46.92
|
-39.51
|
-50.63
|
Net margin
|
-19.86%
|
-3.38%
|
-17.04%
|
-20.29%
|
-29.05%
|
-43.43%
|
-45.55%
|
-38.87%
|
-35.19%
|
-27.98%
|
-32.54%
|
-32.86%
|
-33.44%
|
-26.69%
|
-34.22%
|
EPS
2 |
-0.2500
|
-0.0400
|
-0.2300
|
-0.2500
|
-0.3600
|
-0.5000
|
-0.5400
|
-0.4600
|
-0.4500
|
-0.3600
|
-0.4029
|
-0.4129
|
-0.4286
|
-0.3550
|
-0.4100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/22
|
4/28/22
|
7/28/22
|
10/27/22
|
2/23/23
|
5/4/23
|
7/27/23
|
10/26/23
|
2/22/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
195
|
353
|
450
|
328
|
-
|
59
|
-
|
Net Cash position
1 |
27.9
|
-
|
-
|
-
|
-
|
90.5
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
4.936
x
|
-10.37
x
|
-5.706
x
|
-1.478
x
|
-
|
-0.2997
x
|
-
|
Free Cash Flow
1 |
16.1
|
84.2
|
58.6
|
9.43
|
-100
|
-106
|
-99.8
|
-105
|
ROE (net income / shareholders' equity)
|
-4.38%
|
5.71%
|
-13.2%
|
-21.7%
|
-51.5%
|
-58.7%
|
-105%
|
-113%
|
ROA (Net income/ Total Assets)
|
-1.77%
|
2.59%
|
-5.33%
|
-7.94%
|
-17.7%
|
-17%
|
-22.1%
|
-15.3%
|
Assets
1 |
409.6
|
765.7
|
1,096
|
1,166
|
1,169
|
1,031
|
848.8
|
1,170
|
Book Value Per Share
|
2.190
|
4.660
|
3.950
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
10.5
|
15
|
24.2
|
21.4
|
27.1
|
26
|
33
|
42
|
Capex / Sales
|
2.98%
|
3.03%
|
4.52%
|
3.97%
|
5.32%
|
4.71%
|
5.57%
|
6.38%
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/23/23
|
2/22/24
|
-
|
-
|
-
|
Last Close Price
22.15
USD Average target price
26.36
USD Spread / Average Target +18.99% Consensus |
1st Jan change
|
Capi.
|
---|
| +48.36% | 2.38B | | +75.69% | 12.57B | | -21.92% | 7.61B | | +6.48% | 6.63B | | +15.67% | 5.53B | | -15.85% | 4.89B | | +16.83% | 4.17B | | -21.75% | 3.99B | | -23.78% | 2.88B | | +1.24% | 2.08B |
Medical Equipment
|